Nokomis Capital Raised By $1.01 Million Its Newfield Expl Co (NFX) Holding; Omnicell (OMCL)’s Sentiment Is 1.02

December 11, 2017 - By Vivian Currie

Omnicell, Inc. provides automation and business analytics software solutions for medication and supply management in healthcare worldwide. The company has market cap of $1.93 billion. The firm operates through two divisions, Automation and Analytics, and Medication Adherence. It currently has negative earnings. It offers Omnicell Automated Dispensing Cabinets, a dispensing system, which automates the management and dispensing of medications; SinglePointe, a software product that controls medications; AnywhereRN, which remotely queue medications from automated dispensing cabinets; Omnicell Analytics and Pandora Analytics reporting and data analytics tools; and Savvy Mobile Medication Workstation, which provides a platform for hospital information systems.

Nokomis Capital Llc increased Newfield Expl Co (NFX) stake by 9.39% reported in 2017Q2 SEC filing. Nokomis Capital Llc acquired 36,000 shares as Newfield Expl Co (NFX)’s stock declined 17.43%. The Nokomis Capital Llc holds 419,302 shares with $11.93 million value, up from 383,302 last quarter. Newfield Expl Co now has $5.98 billion valuation. The stock increased 2.99% or $0.88 during the last trading session, reaching $30.27. About 1.26 million shares traded. Newfield Exploration Company (NYSE:NFX) has declined 13.04% since December 11, 2016 and is downtrending. It has underperformed by 29.74% the S&P500.

Among 30 analysts covering Newfield Exploration Co. (NYSE:NFX), 21 have Buy rating, 1 Sell and 8 Hold. Therefore 70% are positive. Newfield Exploration Co. had 98 analyst reports since July 21, 2015 according to SRatingsIntel. The company was maintained on Tuesday, August 29 by Jefferies. The rating was initiated by Canaccord Genuity on Wednesday, June 29 with “Buy”. The firm has “Equal-Weight” rating given on Monday, November 20 by Barclays Capital. RBC Capital Markets maintained Newfield Exploration Company (NYSE:NFX) rating on Thursday, November 5. RBC Capital Markets has “Outperform” rating and $44 target. On Wednesday, December 9 the stock rating was initiated by JP Morgan with “Overweight”. The stock of Newfield Exploration Company (NYSE:NFX) earned “Buy” rating by Cowen & Co on Thursday, October 19. The stock of Newfield Exploration Company (NYSE:NFX) has “Overweight” rating given on Monday, September 18 by PiperJaffray. Citigroup maintained the stock with “Neutral” rating in Monday, September 14 report. Howard Weil upgraded the shares of NFX in report on Monday, December 14 to “Sector Outperform” rating. On Thursday, March 17 the stock rating was maintained by Barclays Capital with “Overweight”.

Investors sentiment increased to 1.09 in 2017 Q2. Its up 0.01, from 1.08 in 2017Q1. It is positive, as 40 investors sold NFX shares while 133 reduced holdings. 48 funds opened positions while 139 raised stakes. 199.90 million shares or 3.61% more from 192.94 million shares in 2017Q1 were reported. Waddell & Reed accumulated 1.84M shares. King Luther Cap Mgmt holds 7,977 shares. 151,354 are held by Envestnet Asset Mgmt Incorporated. C M Bidwell & Associate reported 0% of its portfolio in Newfield Exploration Company (NYSE:NFX). Rainier Inv Lc has invested 0.96% of its portfolio in Newfield Exploration Company (NYSE:NFX). Millennium Mngmt holds 924,889 shares. Parallax Volatility Advisers Limited Partnership stated it has 0% of its portfolio in Newfield Exploration Company (NYSE:NFX). Fincl Bank Of America Corporation De has 1.12 million shares. Tci Wealth Advsrs has 2,000 shares. Macquarie stated it has 334,393 shares or 0.02% of all its holdings. Westwood Hldgs Group Inc holds 95,080 shares or 0.02% of its portfolio. Bamco Ny stated it has 0.01% in Newfield Exploration Company (NYSE:NFX). Tortoise Cap Advisors Ltd Com invested 0.05% of its portfolio in Newfield Exploration Company (NYSE:NFX). Sg Americas Secs Limited Company holds 272,820 shares. Dupont Mngmt Corporation accumulated 4,613 shares.

The stock decreased 0.49% or $0.25 during the last trading session, reaching $50.8. About 201,656 shares traded. Omnicell, Inc. (OMCL) has risen 33.21% since December 11, 2016 and is uptrending. It has outperformed by 16.51% the S&P500.

First Light Asset Management Llc holds 4.02% of its portfolio in Omnicell, Inc. for 278,294 shares. Conestoga Capital Advisors Llc owns 1.61 million shares or 3.6% of their US portfolio. Moreover, Daruma Capital Management Llc has 3.48% invested in the company for 1.35 million shares. The Minnesota-based Kopp Investment Advisors Llc has invested 2.82% in the stock. Oak Ridge Investments Llc, a Illinois-based fund reported 1.54 million shares.

Ratings analysis reveals 100% of Omnicell’s analysts are positive. Out of 2 Wall Street analysts rating Omnicell, 2 give it “Buy”, 0 “Sell” rating, while 0 recommend “Hold”. The lowest target is $44.0 while the high is $55.0. The stock’s average target of $49.50 is -2.56% below today’s ($50.8) share price. OMCL was included in 2 notes of analysts from December 6, 2016. The firm has “Buy” rating given on Thursday, January 19 by Dougherty & Company. The stock of Omnicell, Inc. (NASDAQ:OMCL) has “Buy” rating given on Tuesday, December 6 by Benchmark.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.

Twitter Auto Publish Powered By :